ZENAPAX 5MG/ML
ZENAPAX 5MG/ML
Discontinued
DIN Number
02241473
Drug Class
Human
Market Date
Mar 2, 2000
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02241473
AIG Number0139502001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AC01 DACLIZUMAB
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification90:28.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DACLIZUMABActive
Strength: 5 MG / ML
Monograph: DACLIZUMAB